Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
4.52 Up 0.17(3.91%) Feb 12, 4:00PM EST
|After Hours : 4.52 Up 0.00 (0.02%) Feb 12, 5:07PM EST
Prev Close:4.35
Open:4.39
Bid:1.00 x 100
Ask:6.39 x 500
1y Target Est:9.50
Beta:0.341676
Earnings Date:Mar 11 - Mar 15 (Est.)
Day's Range:4.28 - 4.53
52wk Range:4.14 - 7.74
Volume:675,673
Avg Vol (3m):858,668
Market Cap:308.14M
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIUp 3.91%308.14M
BIIBUp 0.86%54.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.75
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-15) :-0.88
Quarterly EPS Est (Dec-15) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback